BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 28898290)

  • 1. Comparative effectiveness and tolerance of immunosuppressive treatments for idiopathic membranous nephropathy: A network meta-analysis.
    Ren S; Wang Y; Xian L; Toyama T; Jardine M; Li G; Perkovic V; Hong D
    PLoS One; 2017; 12(9):e0184398. PubMed ID: 28898290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.
    Chen Y; Schieppati A; Chen X; Cai G; Zamora J; Giuliano GA; Braun N; Perna A
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD004293. PubMed ID: 25318831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy of 13 immunosuppressive agents for idiopathic membranous nephropathy in adults with nephrotic syndrome: a systematic review and network meta-analysis.
    Zheng Q; Yang H; Liu W; Sun W; Zhao Q; Zhang X; Jin H; Sun L
    BMJ Open; 2019 Sep; 9(9):e030919. PubMed ID: 31511292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of tacrolimus vs cyclophosphamide in the therapy of patients with idiopathic membranous nephropathy: a meta-analysis.
    Lin W; Li HY; Lin S; Zhou T
    Drug Des Devel Ther; 2019; 13():2179-2186. PubMed ID: 31308629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of infection with different immunosuppressive drugs combined with glucocorticoids for the treatment of idiopathic membranous nephropathy: A pairwise and network meta-analysis.
    Liu D; Yang Y; Kuang F; Qing S; Hu B; Yu X
    Int Immunopharmacol; 2019 May; 70():354-361. PubMed ID: 30852290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of tacrolimus monotherapy versus cyclophosphamide-corticosteroid combination therapy for idiopathic membranous nephropathy: A meta-analysis.
    Gong L; Xu M; Xu W; Tang W; Lu J; Jiang W; Xie F; Ding L; Qian X
    Medicine (Baltimore); 2021 Jul; 100(28):e26628. PubMed ID: 34260552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.
    Schieppati A; Perna A; Zamora J; Giuliano GA; Braun N; Remuzzi G
    Cochrane Database Syst Rev; 2004 Oct; (4):CD004293. PubMed ID: 15495098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tacrolimus versus cyclophosphamide for patients with idiopathic membranous nephropathy and treated with steroids: a systematic review and meta-analysis of randomized controlled trials.
    Huang H; Liang Z; Zheng X; Qing Q; Du X; Tang Z; Wei M; Wang C; Zhong Q; Lin X
    Ren Fail; 2021 Dec; 43(1):840-850. PubMed ID: 34016023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppressive treatment for nephrotic idiopathic membranous nephropathy: a meta-analysis based on Chinese adults.
    Xie G; Xu J; Ye C; Chen D; Xu C; Yang L; Ma Y; Hu X; Li L; Sun L; Zhao X; Mao Z; Mei C
    PLoS One; 2012; 7(9):e44330. PubMed ID: 22957065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of low or heavy rituximab‑based protocols and comparison with seven regimens in idiopathic membranous nephropathy: a systematic review and network meta-analysis.
    Chen M; Zhang X; Xiong Y; Xu G
    Int Urol Nephrol; 2023 Mar; 55(3):641-651. PubMed ID: 36161550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of cyclosporine A in the treatment of idiopathic membranous nephropathy in an Asian population.
    Lin S; Li HY; Zhou T; Lin W
    Drug Des Devel Ther; 2019; 13():2305-2330. PubMed ID: 31371924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of Tacrolimus versus Cyclosporine A for Idiopathic Membranous Nephropathy:A Network Meta-analysis.
    Xu P; He YD; Yu ZM; Luo K; Xie HY; Zou PM; Gu X; Wang SR; Cai JF; Xu Q; Li H; Li XW
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Feb; 40(1):41-51. PubMed ID: 29532780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the efficacy and safety of tacrolimus monotherapy and cyclophosphamide combined with glucocorticoid in the treatment of adult primary membranous nephropathy: protocol of a multicenter, randomized, controlled, open study.
    Chen S; Ren S; Wang AY; Tran H; Li Z; Cheng X; Liu M; Li G; Wang L; Hong D
    Trials; 2020 Feb; 21(1):219. PubMed ID: 32093742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacrolimus combined with corticosteroids in idiopathic membranous nephropathy: a randomized, prospective, controlled trial.
    Xu J; Zhang W; Xu Y; Shen P; Ren H; Wang W; Li X; Pan X; Chen N
    Contrib Nephrol; 2013; 181():152-62. PubMed ID: 23689577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of cyclophosphamide versus tacrolimus in terms of treatment effect for idiopathic membranous nephropathy: A meta-analysis.
    Li YC; Huang J; Li X; Zhao SM
    Nefrologia (Engl Ed); 2019; 39(3):269-276. PubMed ID: 30755327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of tacrolimus in idiopathic membranous nephropathy: a meta-analysis.
    Santosh T; Liu H; Liu B
    Chin Med J (Engl); 2014; 127(14):2693-9. PubMed ID: 25043091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and cost of different treatment in patients with idiopathic membranous nephropathy: A network meta-analysis and cost-effectiveness analysis.
    Dai P; Xie W; Yu X; Sun J; Wang S; Kawuki J
    Int Immunopharmacol; 2021 May; 94():107376. PubMed ID: 33582591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of idiopathic membranous nephropathy].
    Passerini P
    G Ital Nefrol; 2004; 21(6):531-9. PubMed ID: 15593020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tacrolimus combined with corticosteroids versus Modified Ponticelli regimen in treatment of idiopathic membranous nephropathy: Randomized control trial.
    Ramachandran R; Hn HK; Kumar V; Nada R; Yadav AK; Goyal A; Kumar V; Rathi M; Jha V; Gupta KL; Sakhuja V; Kohli HS
    Nephrology (Carlton); 2016 Feb; 21(2):139-46. PubMed ID: 26205759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy and safety of tacrolimus monotherapy in adult-onset nephrotic syndrome caused by idiopathic membranous nephropathy.
    Liang Q; Li H; Xie X; Qu F; Li X; Chen J
    Ren Fail; 2017 Nov; 39(1):512-518. PubMed ID: 28562168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.